[
  {
    "": "Reference Guidelines:",
    "CA MTUS Drug List": "",
    "__1": "",
    "__2": ""
  },
  {
    "": "(R)",
    "CA MTUS Drug List": "Recommended",
    "__1": "",
    "__2": ""
  },
  {
    "": "(âœ•)",
    "CA MTUS Drug List": "Not Recommended",
    "__1": "",
    "__2": ""
  },
  {
    "": "(NR)",
    "CA MTUS Drug List": "No Recommendation",
    "__1": "",
    "__2": ""
  },
  {
    "": "",
    "CA MTUS Drug List": "",
    "__1": "",
    "__2": ""
  },
  {
    "": "#",
    "CA MTUS Drug List": "Drug Ingredient",
    "__1": "Reference Brand Name",
    "__2": "General citation (All body parts)"
  },
  {
    "": "",
    "CA MTUS Drug List": "",
    "__1": "",
    "__2": "Citation"
  },
  {
    "": "",
    "CA MTUS Drug List": "",
    "__1": "",
    "__2": "(Effective November 1, 2024)"
  },
  {
    "": 1,
    "CA MTUS Drug List": "acetaminophen",
    "__1": "Tylenol",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: acetaminophen\nBrand Example: Tylenol\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - NonNarcotic\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 2,
    "CA MTUS Drug List": "acetyl l-carnitine",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: acetyl l-carnitine\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Psychotherapeutic and Neurological Agents - Misc\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 3,
    "CA MTUS Drug List": "acyclovir",
    "__1": "Zovirax",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: acyclovir\nBrand Example: Zovirax\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antivirals\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 4,
    "CA MTUS Drug List": "adalimumab",
    "__1": "Humira",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: adalimumab\nBrand Example: Humira\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (TNF-alpha blocker)\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 5,
    "CA MTUS Drug List": "albuterol sulfate",
    "__1": "Proventil",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: albuterol sulfate\nBrand Example: Proventil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 6,
    "CA MTUS Drug List": "alcaftadine",
    "__1": "Lastacaft",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: alcaftadine\nBrand Example: Lastacaft\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 7,
    "CA MTUS Drug List": "alclometasone dipropionate",
    "__1": "Aclovate",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: alclometasone dipropionate\nBrand Example: Aclovate\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 8,
    "CA MTUS Drug List": "alendronate sodium",
    "__1": "Fosamax",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: alendronate sodium\nBrand Example: Fosamax\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate)\nReference in ACOEM Guidelines:\nChronic Pain: Recommended\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: No Recommendation\nLow Back Disorders: Not Recommended\nShoulder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 9,
    "CA MTUS Drug List": "almotriptan malate",
    "__1": "Axert",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: almotriptan malate\nBrand Example: Axert\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 10,
    "CA MTUS Drug List": "alprazolam",
    "__1": "Xanax",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: alprazolam\nBrand Example: Xanax\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended, Not Recommended\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 11,
    "CA MTUS Drug List": "amantadine hcl",
    "__1": "Symmetrel",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: amantadine hcl\nBrand Example: Symmetrel\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiparkinson Agents (NMDA receptor antagonist)\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nLow Back Disorders: Not Recommended\nTraumatic Brain Injury: Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 12,
    "CA MTUS Drug List": "amcinonide",
    "__1": "Cyclocort",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: amcinonide\nBrand Example: Cyclocort\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 13,
    "CA MTUS Drug List": "amitriptyline hcl",
    "__1": "Elavil",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: amitriptyline hcl\nBrand Example: Elavil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 14,
    "CA MTUS Drug List": "amlodipine besylate",
    "__1": "Norvasc",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: amlodipine besylate\nBrand Example: Norvasc\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Calcium Channel Blockers\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 15,
    "CA MTUS Drug List": "amoxapine",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: amoxapine\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 16,
    "CA MTUS Drug List": "amoxicillin/clavulanate p",
    "__1": "Augmentin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: amoxicillin/clavulanate p\nBrand Example: Augmentin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Penicillins)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nLow Back Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 17,
    "CA MTUS Drug List": "anakinra",
    "__1": "Kineret",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: anakinra\nBrand Example: Kineret\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-inflammatory\nReference in ACOEM Guidelines:\nKnee Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 18,
    "CA MTUS Drug List": "apixaban",
    "__1": "Eliquis",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: apixaban\nBrand Example: Eliquis\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: 14 Days\nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 19,
    "CA MTUS Drug List": "aprepitant",
    "__1": "Emend, Cinvanti",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: aprepitant\nBrand Example: Emend, Cinvanti\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 20,
    "CA MTUS Drug List": "aripiprazole",
    "__1": "Abilify",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: aripiprazole\nBrand Example: Abilify\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Antipsychotic/ Antimanic Agents\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 21,
    "CA MTUS Drug List": "artificial tear ointments",
    "__1": "Refresh PM",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: artificial tear ointments\nBrand Example: Refresh PM\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Artificial Tears)\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 22,
    "CA MTUS Drug List": "ascorbic acid",
    "__1": "Vitamin C",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ascorbic acid\nBrand Example: Vitamin C\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 23,
    "CA MTUS Drug List": "aspirin",
    "__1": "Bayer",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: aspirin\nBrand Example: Bayer\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - NonNarcotic\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 24,
    "CA MTUS Drug List": "atenolol",
    "__1": "Tenormin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: atenolol\nBrand Example: Tenormin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Beta Blockers\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 25,
    "CA MTUS Drug List": "atorvastatin calcium",
    "__1": "Lipitor",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: atorvastatin calcium\nBrand Example: Lipitor\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 26,
    "CA MTUS Drug List": "azelastine ophth",
    "__1": "Optivar",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: azelastine ophth\nBrand Example: Optivar\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 27,
    "CA MTUS Drug List": "azithromycin",
    "__1": "Zithromax",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: azithromycin\nBrand Example: Zithromax\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Macrolides)\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 28,
    "CA MTUS Drug List": "azithromycin ophth",
    "__1": "Azasite",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: azithromycin ophth\nBrand Example: Azasite\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Macrolides)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 29,
    "CA MTUS Drug List": "bacitracin",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: bacitracin\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anti-Infective Agents - Misc.\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nHand, Wrist, and Forearm Disorders: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 30,
    "CA MTUS Drug List": "baclofen",
    "__1": "Lioresal",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: baclofen\nBrand Example: Lioresal\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 31,
    "CA MTUS Drug List": "baricitinib",
    "__1": "Olumiant",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: baricitinib\nBrand Example: Olumiant\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 32,
    "CA MTUS Drug List": "becaplermin",
    "__1": "Regranex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: becaplermin\nBrand Example: Regranex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 33,
    "CA MTUS Drug List": "beclomethasone dipropionate",
    "__1": "Qvar",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: beclomethasone dipropionate\nBrand Example: Qvar\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 34,
    "CA MTUS Drug List": "bepotastine ophth",
    "__1": "Bepreve",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: bepotastine ophth\nBrand Example: Bepreve\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 35,
    "CA MTUS Drug List": "besifloxacin ophth",
    "__1": "Besivance",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: besifloxacin ophth\nBrand Example: Besivance\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Topical antibiotic\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 36,
    "CA MTUS Drug List": "betamethasone",
    "__1": "Celestone",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: betamethasone\nBrand Example: Celestone\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 37,
    "CA MTUS Drug List": "betamethasone dipropionat",
    "__1": "Diprosone",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: betamethasone dipropionat\nBrand Example: Diprosone\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 38,
    "CA MTUS Drug List": "betamethasone valerate",
    "__1": "Valisone",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: betamethasone valerate\nBrand Example: Valisone\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 39,
    "CA MTUS Drug List": "boswellia serrata extract",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: boswellia serrata extract\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Chemicals\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 40,
    "CA MTUS Drug List": "brexpiprazole",
    "__1": "Rexulti",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: brexpiprazole\nBrand Example: Rexulti\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 41,
    "CA MTUS Drug List": "bromfenac",
    "__1": "Prolensa",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: bromfenac\nBrand Example: Prolensa\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (NSAID)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 42,
    "CA MTUS Drug List": "bromocriptine mesylate",
    "__1": "Parlodel",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: bromocriptine mesylate\nBrand Example: Parlodel\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiparkinson and Related Therapy Agents\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 43,
    "CA MTUS Drug List": "budesonide",
    "__1": "Pulmicort",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: budesonide\nBrand Example: Pulmicort\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 44,
    "CA MTUS Drug List": "budesonide/formoterol",
    "__1": "Symbicort",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: budesonide/formoterol\nBrand Example: Symbicort\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 45,
    "CA MTUS Drug List": "buprenorphine",
    "__1": "Butrans",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: buprenorphine\nBrand Example: Butrans\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics-Opioid\nReference in ACOEM Guidelines:\nOpioids: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 46,
    "CA MTUS Drug List": "buprenorphine (hcl)",
    "__1": "Belbuca",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: buprenorphine (hcl)\nBrand Example: Belbuca\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioid: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 47,
    "CA MTUS Drug List": "buprenorphine hcl/naloxone",
    "__1": "Suboxone, Zubsolv",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: buprenorphine hcl/naloxone\nBrand Example: Suboxone, Zubsolv\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioid: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 48,
    "CA MTUS Drug List": "bupropion hcl",
    "__1": "Wellbutrin, Wellbutrin XL, Wellbutrin SR",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: bupropion hcl\nBrand Example: Wellbutrin, Wellbutrin XL, Wellbutrin SR\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended, No Recommendation\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Not Recommended\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 49,
    "CA MTUS Drug List": "buspirone hcl",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: buspirone hcl\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 50,
    "CA MTUS Drug List": "butalbital/apap/caffeine",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: butalbital/apap/caffeine\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - NonNarcotic\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 51,
    "CA MTUS Drug List": "butalbital/asa/caffeine",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: butalbital/asa/caffeine\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - NonNarcotic\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 52,
    "CA MTUS Drug List": "butenafine hcl",
    "__1": "Lotrimin Ultra",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: butenafine hcl\nBrand Example: Lotrimin Ultra\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 53,
    "CA MTUS Drug List": "butorphanol tartrate",
    "__1": "Stadol",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: butorphanol tartrate\nBrand Example: Stadol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 54,
    "CA MTUS Drug List": "cabergoline",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: cabergoline\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Endocrine and Metabolic Agents - Misc.\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 55,
    "CA MTUS Drug List": "calcitonin-salmon",
    "__1": "Fortical, Miacalcin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: calcitonin-salmon\nBrand Example: Fortical, Miacalcin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 56,
    "CA MTUS Drug List": "calcium phosphate tribasic",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: calcium phosphate tribasic\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Minerals & Electrolytes\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 57,
    "CA MTUS Drug List": "camphor",
    "__1": "Bengay Ultra",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: camphor\nBrand Example: Bengay Ultra\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: No Recommendation\nChronic Pain: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 58,
    "CA MTUS Drug List": "capsaicin",
    "__1": "Zostrix",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: capsaicin\nBrand Example: Zostrix\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals (Topical creams and ointments)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 59,
    "CA MTUS Drug List": "carbamazepine",
    "__1": "Tegretol",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: carbamazepine\nBrand Example: Tegretol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation\nLow Back Disorders: No Recommendation\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 60,
    "CA MTUS Drug List": "carboxymethylcellulose-glycerin ophth gel",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: carboxymethylcellulose-glycerin ophth gel\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 61,
    "CA MTUS Drug List": "carboxymethylcellulose sodium ophthalmic",
    "__1": "Refresh Plus",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: carboxymethylcellulose sodium ophthalmic\nBrand Example: Refresh Plus\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Artificial Tears)\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 62,
    "CA MTUS Drug List": "carisoprodol",
    "__1": "Soma",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: carisoprodol\nBrand Example: Soma\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 63,
    "CA MTUS Drug List": "cefadroxil",
    "__1": "Duracef",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: cefadroxil\nBrand Example: Duracef\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Cephalosporins\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 64,
    "CA MTUS Drug List": "cefuroxime axetil",
    "__1": "Ceftin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: cefuroxime axetil\nBrand Example: Ceftin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Cephalosporins)\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 65,
    "CA MTUS Drug List": "celecoxib",
    "__1": "Celebrex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: celecoxib\nBrand Example: Celebrex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nDepressive Disorders: Not Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 66,
    "CA MTUS Drug List": "cephalexin",
    "__1": "Keflex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: cephalexin\nBrand Example: Keflex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Cephalosporins)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 67,
    "CA MTUS Drug List": "certolizumab pegol",
    "__1": "Cimzia",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: certolizumab pegol\nBrand Example: Cimzia\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Gastrointestinal Agents (TNF Blocker)\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 68,
    "CA MTUS Drug List": "chlordiazepoxide hcl",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: chlordiazepoxide hcl\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 69,
    "CA MTUS Drug List": "chloroquine phosphate",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: chloroquine phosphate\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antimalarials\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 70,
    "CA MTUS Drug List": "chlorzoxazone",
    "__1": "Lorzone, Parafon Forte",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: chlorzoxazone\nBrand Example: Lorzone, Parafon Forte\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 71,
    "CA MTUS Drug List": "choline magnesium trisalicylate",
    "__1": "Trilisate",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: choline magnesium trisalicylate\nBrand Example: Trilisate\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - NonNarcotic (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 72,
    "CA MTUS Drug List": "chondroitin sulfate",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: chondroitin sulfate\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Alternative Medicines (OTC nutraceutical)\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: No Recommendation\nHip and Groin Disorders: No Recommendation\nKnee Disorders: No Recommendation\nShoulder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 73,
    "CA MTUS Drug List": "ciclesonide",
    "__1": "Alvesco",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ciclesonide\nBrand Example: Alvesco\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 74,
    "CA MTUS Drug List": "ciclopirox olamine",
    "__1": "Loprox",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ciclopirox olamine\nBrand Example: Loprox\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 75,
    "CA MTUS Drug List": "cimetidine",
    "__1": "Tagamet",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: cimetidine\nBrand Example: Tagamet\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ulcer Drugs (H2 receptor blocker)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 76,
    "CA MTUS Drug List": "ciprofloxacin",
    "__1": "Cipro",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ciprofloxacin\nBrand Example: Cipro\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Fluoroquinolones)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 77,
    "CA MTUS Drug List": "ciprofloxacin hcl ophthalmic",
    "__1": "Ciloxan",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ciprofloxacin hcl ophthalmic\nBrand Example: Ciloxan\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Antibiotics)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 78,
    "CA MTUS Drug List": "citalopram hydrobromide",
    "__1": "Celexa",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: citalopram hydrobromide\nBrand Example: Celexa\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended, Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 79,
    "CA MTUS Drug List": "citicoline",
    "__1": "Ceraxon",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: citicoline\nBrand Example: Ceraxon\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Alternative Medicines\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 80,
    "CA MTUS Drug List": "clarithromycin",
    "__1": "Biaxin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: clarithromycin\nBrand Example: Biaxin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Macrolides)\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 81,
    "CA MTUS Drug List": "clindamycin hcl",
    "__1": "Cleocin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: clindamycin hcl\nBrand Example: Cleocin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anti-Infective Agents - Misc.\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 82,
    "CA MTUS Drug List": "clomipramine hcl",
    "__1": "Anafranil",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: clomipramine hcl\nBrand Example: Anafranil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 83,
    "CA MTUS Drug List": "clonazepam",
    "__1": "Klonopin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: clonazepam\nBrand Example: Klonopin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended, Not Recommended\nLow Back Disorders: No Recommendation\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 84,
    "CA MTUS Drug List": "clonidine",
    "__1": "Catapres",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: clonidine\nBrand Example: Catapres\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihypertensives\nReference in ACOEM Guidelines:\nOpioids: Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 85,
    "CA MTUS Drug List": "clorazepate dipotassium",
    "__1": "Tranxene T",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: clorazepate dipotassium\nBrand Example: Tranxene T\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Antiaxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 86,
    "CA MTUS Drug List": "clotrimazole antifungal",
    "__1": "Lotrimin AF",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: clotrimazole antifungal\nBrand Example: Lotrimin AF\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 87,
    "CA MTUS Drug List": "codeine sulfate",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: codeine sulfate\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 88,
    "CA MTUS Drug List": "codeine/acetaminophen",
    "__1": "Tylenol #3, Tylenol #4",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: codeine/acetaminophen\nBrand Example: Tylenol #3, Tylenol #4\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 89,
    "CA MTUS Drug List": "coenzyme q10",
    "__1": "CoQ10",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: coenzyme q10\nBrand Example: CoQ10\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Alternative Medicines\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 90,
    "CA MTUS Drug List": "colchicine",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: colchicine\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Gout Agents\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 91,
    "CA MTUS Drug List": "cortisone",
    "__1": "Cortone",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: cortisone\nBrand Example: Cortone\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, No Recommendation\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 92,
    "CA MTUS Drug List": "creatine monohydrate",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: creatine monohydrate\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Chemicals\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 93,
    "CA MTUS Drug List": "cromolyn sodium",
    "__1": "Intal",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: cromolyn sodium\nBrand Example: Intal\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 94,
    "CA MTUS Drug List": "cromolyn sodium (opthalmic)",
    "__1": "Opticrom",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: cromolyn sodium (opthalmic)\nBrand Example: Opticrom\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 95,
    "CA MTUS Drug List": "cyclobenzaprine hcl",
    "__1": "Flexeril",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: cyclobenzaprine hcl\nBrand Example: Flexeril\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 96,
    "CA MTUS Drug List": "cyclopentolate hcl",
    "__1": "Cyclogyl",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: cyclopentolate hcl\nBrand Example: Cyclogyl\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Anticholinergics)\nReference in ACOEM Guidelines:\nEye: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 97,
    "CA MTUS Drug List": "cyclosporine",
    "__1": "Sandimmune",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: cyclosporine\nBrand Example: Sandimmune\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Miscellaneous Therapeutic Classes\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 98,
    "CA MTUS Drug List": "dalteparin",
    "__1": "Fragmin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: dalteparin\nBrand Example: Fragmin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 99,
    "CA MTUS Drug List": "dantrolene sodium",
    "__1": "Dantrium",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: dantrolene sodium\nBrand Example: Dantrium\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 100,
    "CA MTUS Drug List": "dehydroepiandrosterone (dhea)",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: dehydroepiandrosterone (dhea)\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Chemicals\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 101,
    "CA MTUS Drug List": "desipramine hcl",
    "__1": "Norpramin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: desipramine hcl\nBrand Example: Norpramin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 102,
    "CA MTUS Drug List": "desloratadine",
    "__1": "Clarinex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: desloratadine\nBrand Example: Clarinex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 103,
    "CA MTUS Drug List": "desmopressin acetate",
    "__1": "DDAVP",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: desmopressin acetate\nBrand Example: DDAVP\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Endocrine and Metabolic Agents - Misc.\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 104,
    "CA MTUS Drug List": "desonide",
    "__1": "Desowen",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: desonide\nBrand Example: Desowen\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 105,
    "CA MTUS Drug List": "desoximetasone",
    "__1": "Topicort",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: desoximetasone\nBrand Example: Topicort\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 106,
    "CA MTUS Drug List": "desvenlafaxine",
    "__1": "Khedezla",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: desvenlafaxine\nBrand Example: Khedezla\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended, No Recommendation\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 107,
    "CA MTUS Drug List": "desvenlafaxine succinate",
    "__1": "Pristiq",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: desvenlafaxine succinate\nBrand Example: Pristiq\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended, No Recommendation\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 108,
    "CA MTUS Drug List": "dexamethasone",
    "__1": "Decadron",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: dexamethasone\nBrand Example: Decadron\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nCOVID-19 Coronavirus: Recommended\nElbow Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 109,
    "CA MTUS Drug List": "dexamethasone sodium phosphate ophthalmic",
    "__1": "Maxidex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: dexamethasone sodium phosphate ophthalmic\nBrand Example: Maxidex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Steroid)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 110,
    "CA MTUS Drug List": "dexlansoprazole",
    "__1": "Dexilant",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: dexlansoprazole\nBrand Example: Dexilant\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 111,
    "CA MTUS Drug List": "dextromethorphan",
    "__1": "Delsym",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: dextromethorphan\nBrand Example: Delsym\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Cough/Cold/Allergy (NMDA Receptor Antagonist)\nReference in ACOEM Guidelines:\nChronic Pain: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 112,
    "CA MTUS Drug List": "dextromethorphan-quinidine sulfate",
    "__1": "Nuedexta",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: dextromethorphan-quinidine sulfate\nBrand Example: Nuedexta\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Psychotherapeutic and Neurological Agents-Misc.\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 113,
    "CA MTUS Drug List": "diazepam",
    "__1": "Valium",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: diazepam\nBrand Example: Valium\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended, Not Recommended\nChronic Pain: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 114,
    "CA MTUS Drug List": "diclofenac epolamine",
    "__1": "Flector",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: diclofenac epolamine\nBrand Example: Flector\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 115,
    "CA MTUS Drug List": "diclofenac potassium",
    "__1": "Cataflam",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: diclofenac potassium\nBrand Example: Cataflam\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: No Recommendation\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 116,
    "CA MTUS Drug List": "diclofenac sodium",
    "__1": "Voltaren",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: diclofenac sodium\nBrand Example: Voltaren\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics â€“ Anti-Inflammatory\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: No Recommendation\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 117,
    "CA MTUS Drug List": "diclofenac sodium (topical)",
    "__1": "Voltaren 1% gel",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: diclofenac sodium (topical)\nBrand Example: Voltaren 1% gel\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: No Recommendation\nChronic Pain: Recommended\nElbow Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nShoulder: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 118,
    "CA MTUS Drug List": "diclofenac sodium ophthalmic",
    "__1": "Voltaren",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: diclofenac sodium ophthalmic\nBrand Example: Voltaren\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (NSAID)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 119,
    "CA MTUS Drug List": "diclofenac sodium/misoprostol",
    "__1": "Arthrotec",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: diclofenac sodium/misoprostol\nBrand Example: Arthrotec\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID/ Ulcer drug)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 120,
    "CA MTUS Drug List": "dicloxacillin sodium",
    "__1": "Dynapen",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: dicloxacillin sodium\nBrand Example: Dynapen\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Penicillins)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 121,
    "CA MTUS Drug List": "diflunisal",
    "__1": "Dolobid",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: diflunisal\nBrand Example: Dolobid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 122,
    "CA MTUS Drug List": "dihydroergotamine mesylat",
    "__1": "Migranal",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: dihydroergotamine mesylat\nBrand Example: Migranal\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 123,
    "CA MTUS Drug List": "dimenhydrinate",
    "__1": "Dramamine",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: dimenhydrinate\nBrand Example: Dramamine\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 124,
    "CA MTUS Drug List": "dimethyl sulfoxide",
    "__1": "DMSO",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: dimethyl sulfoxide\nBrand Example: DMSO\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Genitourinary - Misc. (Ointments and topical agents)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended\nHip and Groin Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 125,
    "CA MTUS Drug List": "divalproex sodium",
    "__1": "Depakote",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: divalproex sodium\nBrand Example: Depakote\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nLow Back Disorders: No Recommendation\nPost-Traumatic Stress Disorder: Not Recommended\nTraumatic Brain Injury: Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 126,
    "CA MTUS Drug List": "dolasetron mesylate",
    "__1": "Anzemet",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: dolasetron mesylate\nBrand Example: Anzemet\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nChronic Pain: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 127,
    "CA MTUS Drug List": "donepezil hcl",
    "__1": "Aricept",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: donepezil hcl\nBrand Example: Aricept\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Psychotherapeutic and Neurological Agents-Misc.\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 128,
    "CA MTUS Drug List": "doxazosin mesylate",
    "__1": "Cardura",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: doxazosin mesylate\nBrand Example: Cardura\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihypertensives\nReference in ACOEM Guidelines:\nPost-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 129,
    "CA MTUS Drug List": "doxepin hcl",
    "__1": "Sinequan",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: doxepin hcl\nBrand Example: Sinequan\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 130,
    "CA MTUS Drug List": "doxycycline",
    "__1": "Vibramycin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: doxycycline\nBrand Example: Vibramycin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Tetracyclines)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 131,
    "CA MTUS Drug List": "droperidol",
    "__1": "Inapsine",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: droperidol\nBrand Example: Inapsine\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 132,
    "CA MTUS Drug List": "duloxetine hcl",
    "__1": "Cymbalta",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: duloxetine hcl\nBrand Example: Cymbalta\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 133,
    "CA MTUS Drug List": "econazole nitrate",
    "__1": "Spectazole",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: econazole nitrate\nBrand Example: Spectazole\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 134,
    "CA MTUS Drug List": "edoxaban tosylate",
    "__1": "Savaysa",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: edoxaban tosylate\nBrand Example: Savaysa\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 135,
    "CA MTUS Drug List": "eletriptan hydrobromide",
    "__1": "Relpax",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: eletriptan hydrobromide\nBrand Example: Relpax\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 136,
    "CA MTUS Drug List": "enoxaparin sodium",
    "__1": "Lovenox",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: enoxaparin sodium\nBrand Example: Lovenox\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 137,
    "CA MTUS Drug List": "epinastine hcl",
    "__1": "Elestat",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: epinastine hcl\nBrand Example: Elestat\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 138,
    "CA MTUS Drug List": "erythromycin",
    "__1": "Ery-Tab",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: erythromycin\nBrand Example: Ery-Tab\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Macrolides)\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 139,
    "CA MTUS Drug List": "erythromycin ophthalmic ointment",
    "__1": "Ilotycin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: erythromycin ophthalmic ointment\nBrand Example: Ilotycin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Antibiotics)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 140,
    "CA MTUS Drug List": "escitalopram oxalate",
    "__1": "Lexapro",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: escitalopram oxalate\nBrand Example: Lexapro\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended, Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 141,
    "CA MTUS Drug List": "esketamine",
    "__1": "Spravato",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: esketamine\nBrand Example: Spravato\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nDepressive Disorders: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 142,
    "CA MTUS Drug List": "esomeprazole magnesium",
    "__1": "Nexium",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: esomeprazole magnesium\nBrand Example: Nexium\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 143,
    "CA MTUS Drug List": "esomeprazole/naproxen",
    "__1": "Vimovo",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: esomeprazole/naproxen\nBrand Example: Vimovo\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (Proton Pump Inhibitor /NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 144,
    "CA MTUS Drug List": "estradiol",
    "__1": "Climara, Estraderm",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: estradiol\nBrand Example: Climara, Estraderm\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Estrogens\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 145,
    "CA MTUS Drug List": "eszopiclone",
    "__1": "Lunesta",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: eszopiclone\nBrand Example: Lunesta\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 146,
    "CA MTUS Drug List": "etanercept",
    "__1": "Enbrel",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: etanercept\nBrand Example: Enbrel\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (TNF-alpha blocker)\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 147,
    "CA MTUS Drug List": "etidronate disodium",
    "__1": "Didronel",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: etidronate disodium\nBrand Example: Didronel\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate)\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 148,
    "CA MTUS Drug List": "etodolac",
    "__1": "Lodine",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: etodolac\nBrand Example: Lodine\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 149,
    "CA MTUS Drug List": "famciclovir",
    "__1": "Famvir",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: famciclovir\nBrand Example: Famvir\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antivirals\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 150,
    "CA MTUS Drug List": "famotidine",
    "__1": "Pepcid",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: famotidine\nBrand Example: Pepcid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ulcer Drugs (H2 receptor blocker)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 151,
    "CA MTUS Drug List": "famotidine/ibuprofen",
    "__1": "Duexis",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: famotidine/ibuprofen\nBrand Example: Duexis\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (H2 Receptor Blocker /NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 152,
    "CA MTUS Drug List": "fenoprofen calcium",
    "__1": "Nalfon",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fenoprofen calcium\nBrand Example: Nalfon\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 153,
    "CA MTUS Drug List": "fentanyl",
    "__1": "Duragesic",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fentanyl\nBrand Example: Duragesic\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 154,
    "CA MTUS Drug List": "fentanyl citrate oral transmucosal",
    "__1": "Actiq, Fentora",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fentanyl citrate oral transmucosal\nBrand Example: Actiq, Fentora\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 155,
    "CA MTUS Drug List": "fluconazole",
    "__1": "Diflucan",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fluconazole\nBrand Example: Diflucan\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antifungals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 156,
    "CA MTUS Drug List": "fluocinolone acetonide",
    "__1": "Synalar",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fluocinolone acetonide\nBrand Example: Synalar\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 157,
    "CA MTUS Drug List": "fluocinonide",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fluocinonide\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nElbow Disorders: Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 158,
    "CA MTUS Drug List": "fluorometholone",
    "__1": "FML",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fluorometholone\nBrand Example: FML\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 159,
    "CA MTUS Drug List": "fluoxetine hcl",
    "__1": "Prozac",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fluoxetine hcl\nBrand Example: Prozac\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended, Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 160,
    "CA MTUS Drug List": "flurbiprofen",
    "__1": "Ansaid",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: flurbiprofen\nBrand Example: Ansaid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 161,
    "CA MTUS Drug List": "flurbiprofen sodium",
    "__1": "Ocufen",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: flurbiprofen sodium\nBrand Example: Ocufen\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anti-Inflammatory (NSAID) Ophthalmic Drops\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 162,
    "CA MTUS Drug List": "fluticasone prop (topical)",
    "__1": "Cutivate",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fluticasone prop (topical)\nBrand Example: Cutivate\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 163,
    "CA MTUS Drug List": "fluticasone propionate",
    "__1": "Flovent",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fluticasone propionate\nBrand Example: Flovent\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 164,
    "CA MTUS Drug List": "fluticasone-salmeterol",
    "__1": "Advair",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fluticasone-salmeterol\nBrand Example: Advair\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 165,
    "CA MTUS Drug List": "fluvastatin sodium er",
    "__1": "Lescol XL",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fluvastatin sodium er\nBrand Example: Lescol XL\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 166,
    "CA MTUS Drug List": "fluvoxamine maleate",
    "__1": "Luvox",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fluvoxamine maleate\nBrand Example: Luvox\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 167,
    "CA MTUS Drug List": "folic acid",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: folic acid\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Hematopoietic Agents\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nDepressive Disorders: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 168,
    "CA MTUS Drug List": "fondaparinux sodium",
    "__1": "Arixtra",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: fondaparinux sodium\nBrand Example: Arixtra\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 169,
    "CA MTUS Drug List": "formoterol fumarate",
    "__1": "Foradil",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: formoterol fumarate\nBrand Example: Foradil\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 170,
    "CA MTUS Drug List": "formoterol/mometasone",
    "__1": "Dulera",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: formoterol/mometasone\nBrand Example: Dulera\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 171,
    "CA MTUS Drug List": "frovatriptan succinate",
    "__1": "Frova",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: frovatriptan succinate\nBrand Example: Frova\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 172,
    "CA MTUS Drug List": "gabapentin",
    "__1": "Neurontin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: gabapentin\nBrand Example: Neurontin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: 4 Days\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nAnxiety Disorders: No Recommendation\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended, No Recommendation\nChronic Pain: Recommended\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: Not Recommended\nShoulder: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 173,
    "CA MTUS Drug List": "gabapentin (once-daily)",
    "__1": "Gralise",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: gabapentin (once-daily)\nBrand Example: Gralise\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Psychotherapeutic and Neurological Agents - Misc\nReference in ACOEM Guidelines:\nAnxiety Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 174,
    "CA MTUS Drug List": "gabapentin enacarbil",
    "__1": "Horizant",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: gabapentin enacarbil\nBrand Example: Horizant\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Psychotherapeutic and Neurological Agents - Misc\nReference in ACOEM Guidelines:\nAnxiety Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nHip and Groin Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 175,
    "CA MTUS Drug List": "gatifloxacin",
    "__1": "Zymaxid",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: gatifloxacin\nBrand Example: Zymaxid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 176,
    "CA MTUS Drug List": "gentamicin (topical)",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: gentamicin (topical)\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 177,
    "CA MTUS Drug List": "gentamicin sulfate ophthalmic",
    "__1": "Gentak",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: gentamicin sulfate ophthalmic\nBrand Example: Gentak\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 178,
    "CA MTUS Drug List": "glucosamine sulfate",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: glucosamine sulfate\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Alternative Medicines (OTC nutraceutical)\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: No Recommendation\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended\nShoulder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 179,
    "CA MTUS Drug List": "golimumab",
    "__1": "Simponi",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: golimumab\nBrand Example: Simponi\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (TNF-alpha blocker)\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 180,
    "CA MTUS Drug List": "granisetron hcl",
    "__1": "Kytril",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: granisetron hcl\nBrand Example: Kytril\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 181,
    "CA MTUS Drug List": "guanfacine er",
    "__1": "Intuniv",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: guanfacine er\nBrand Example: Intuniv\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: ADHD/Anti-Narcolepsy/Anti-Obesity/Anorexiants\nReference in ACOEM Guidelines:\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 182,
    "CA MTUS Drug List": "guanfacine hcl",
    "__1": "Tenex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: guanfacine hcl\nBrand Example: Tenex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihypertensives\nReference in ACOEM Guidelines:\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 183,
    "CA MTUS Drug List": "heparin sodium",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: heparin sodium\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 184,
    "CA MTUS Drug List": "homatropine hbr ophthalmic",
    "__1": "Isopto Homatropine",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: homatropine hbr ophthalmic\nBrand Example: Isopto Homatropine\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Anticholinergics)\nReference in ACOEM Guidelines:\nEye: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 185,
    "CA MTUS Drug List": "hydrochlorothiazide",
    "__1": "Microzide",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: hydrochlorothiazide\nBrand Example: Microzide\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Diuretics\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 186,
    "CA MTUS Drug List": "hydrocodone bitartrate",
    "__1": "Hysingla ER",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: hydrocodone bitartrate\nBrand Example: Hysingla ER\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 187,
    "CA MTUS Drug List": "hydrocodone/acetaminophen",
    "__1": "Norco, Vicodin, Xodol",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: hydrocodone/acetaminophen\nBrand Example: Norco, Vicodin, Xodol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nOpioids: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 188,
    "CA MTUS Drug List": "hydrocodone/ibuprofen",
    "__1": "Vicoprofen",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: hydrocodone/ibuprofen\nBrand Example: Vicoprofen\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 189,
    "CA MTUS Drug List": "hydrocortisone",
    "__1": "Cortef",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: hydrocortisone\nBrand Example: Cortef\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nCOVID-19 Coronavirus: Recommended\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Not Recommended\nKnee Disorders: No Recommendation\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 190,
    "CA MTUS Drug List": "hydrocortisone (topical)",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: hydrocortisone (topical)\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 191,
    "CA MTUS Drug List": "hydrocortisone valerate",
    "__1": "Westcort",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: hydrocortisone valerate\nBrand Example: Westcort\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 192,
    "CA MTUS Drug List": "hydromorphone hcl",
    "__1": "Dilaudid, Exalgo",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: hydromorphone hcl\nBrand Example: Dilaudid, Exalgo\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 193,
    "CA MTUS Drug List": "hydroxychloroquine sulfate",
    "__1": "Plaquenil",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: hydroxychloroquine sulfate\nBrand Example: Plaquenil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antimalarials\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 194,
    "CA MTUS Drug List": "hydroxyzine hcl",
    "__1": "Atarax",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: hydroxyzine hcl\nBrand Example: Atarax\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 195,
    "CA MTUS Drug List": "hydroxyzine pamoate",
    "__1": "Vistaril",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: hydroxyzine pamoate\nBrand Example: Vistaril\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 196,
    "CA MTUS Drug List": "hypromellose ophthalmic gel",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: hypromellose ophthalmic gel\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 197,
    "CA MTUS Drug List": "ibandronate sodium",
    "__1": "Boniva",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ibandronate sodium\nBrand Example: Boniva\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate)\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 198,
    "CA MTUS Drug List": "ibuprofen",
    "__1": "Motrin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ibuprofen\nBrand Example: Motrin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 199,
    "CA MTUS Drug List": "imipramine hcl",
    "__1": "Tofranil",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: imipramine hcl\nBrand Example: Tofranil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 200,
    "CA MTUS Drug List": "imipramine pamoate",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: imipramine pamoate\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 201,
    "CA MTUS Drug List": "indomethacin",
    "__1": "Indocin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: indomethacin\nBrand Example: Indocin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 202,
    "CA MTUS Drug List": "inositol",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: inositol\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Nutrients\nReference in ACOEM Guidelines:\nPost-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 203,
    "CA MTUS Drug List": "irrigating eyewash",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: irrigating eyewash\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 204,
    "CA MTUS Drug List": "isocarboxazid",
    "__1": "Marplan",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: isocarboxazid\nBrand Example: Marplan\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 205,
    "CA MTUS Drug List": "itraconazole",
    "__1": "Sporanox",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: itraconazole\nBrand Example: Sporanox\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antifungals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 206,
    "CA MTUS Drug List": "ivermectin",
    "__1": "Stomectol",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ivermectin\nBrand Example: Stomectol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihelmintics\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 207,
    "CA MTUS Drug List": "ketoconazole",
    "__1": "Nizoral",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ketoconazole\nBrand Example: Nizoral\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 208,
    "CA MTUS Drug List": "ketoprofen",
    "__1": "Oruvail",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ketoprofen\nBrand Example: Oruvail\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 209,
    "CA MTUS Drug List": "ketorolac tromethamine",
    "__1": "Toradol",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ketorolac tromethamine\nBrand Example: Toradol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 210,
    "CA MTUS Drug List": "ketorolac tromethamine ophthalmic",
    "__1": "Acular",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ketorolac tromethamine ophthalmic\nBrand Example: Acular\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (NSAID)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 211,
    "CA MTUS Drug List": "ketotifen fumarate",
    "__1": "Zaditor",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ketotifen fumarate\nBrand Example: Zaditor\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 212,
    "CA MTUS Drug List": "lamotrigine",
    "__1": "Lamictal",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lamotrigine\nBrand Example: Lamictal\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation\nLow Back Disorders: No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 213,
    "CA MTUS Drug List": "lansoprazole",
    "__1": "Prevacid",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lansoprazole\nBrand Example: Prevacid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 214,
    "CA MTUS Drug List": "lenalidomide",
    "__1": "Revlimid",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lenalidomide\nBrand Example: Revlimid\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Miscellaneous Therapeutic Classes\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 215,
    "CA MTUS Drug List": "levalbuterol",
    "__1": "Xopenex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: levalbuterol\nBrand Example: Xopenex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 216,
    "CA MTUS Drug List": "levetiracetam",
    "__1": "Keppra",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: levetiracetam\nBrand Example: Keppra\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 217,
    "CA MTUS Drug List": "levofloxacin",
    "__1": "Levaquin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: levofloxacin\nBrand Example: Levaquin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Fluoroquinolones)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 218,
    "CA MTUS Drug List": "levofloxacin ophthalmic solution",
    "__1": "Quixin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: levofloxacin ophthalmic solution\nBrand Example: Quixin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 219,
    "CA MTUS Drug List": "levomilnacipran",
    "__1": "Fetzima",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: levomilnacipran\nBrand Example: Fetzima\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 220,
    "CA MTUS Drug List": "levorphanol tartrate",
    "__1": "Levo-Dromoran",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: levorphanol tartrate\nBrand Example: Levo-Dromoran\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 221,
    "CA MTUS Drug List": "lidocaine",
    "__1": "Lidoderm",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lidocaine\nBrand Example: Lidoderm\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, No Recommendation\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended, No Recommendation\nLow Back Disorders (Recommended, Not Recommended, No Recommendation) Shoulder: Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 222,
    "CA MTUS Drug List": "lidocaine hcl",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lidocaine hcl\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 223,
    "CA MTUS Drug List": "lidocaine hcl ophth",
    "__1": "Akten",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lidocaine hcl ophth\nBrand Example: Akten\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Opthalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 224,
    "CA MTUS Drug List": "lidocaine/prilocaine",
    "__1": "Emla",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lidocaine/prilocaine\nBrand Example: Emla\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 225,
    "CA MTUS Drug List": "lithium carbonate",
    "__1": "Lithobid",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lithium carbonate\nBrand Example: Lithobid\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 226,
    "CA MTUS Drug List": "lodoxamide ophth",
    "__1": "Alomide",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lodoxamide ophth\nBrand Example: Alomide\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 227,
    "CA MTUS Drug List": "lofexidine",
    "__1": "Lucemyra",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lofexidine\nBrand Example: Lucemyra\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Psychotherapeutic and Neurological Agents - Misc\nReference in ACOEM Guidelines:\nOpioids: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 228,
    "CA MTUS Drug List": "lopinavir/ritonavir",
    "__1": "Kaletra",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lopinavir/ritonavir\nBrand Example: Kaletra\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antivirals\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 229,
    "CA MTUS Drug List": "loratadine",
    "__1": "Claritin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: loratadine\nBrand Example: Claritin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 230,
    "CA MTUS Drug List": "lorazepam",
    "__1": "Ativan",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lorazepam\nBrand Example: Ativan\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended, Not Recommended\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 231,
    "CA MTUS Drug List": "loteprednol etabonate ophthalmic",
    "__1": "Alrex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: loteprednol etabonate ophthalmic\nBrand Example: Alrex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Steroid)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 232,
    "CA MTUS Drug List": "lovastatin",
    "__1": "Mevacor",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lovastatin\nBrand Example: Mevacor\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 233,
    "CA MTUS Drug List": "lurasidone",
    "__1": "Latuda",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: lurasidone\nBrand Example: Latuda\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 234,
    "CA MTUS Drug List": "magnesium",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: magnesium\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Minerals & Electrolytes\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 235,
    "CA MTUS Drug List": "meclizine hcl",
    "__1": "Antivert",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: meclizine hcl\nBrand Example: Antivert\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 236,
    "CA MTUS Drug List": "meclofenamate sodium",
    "__1": "Meclomen",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: meclofenamate sodium\nBrand Example: Meclomen\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 237,
    "CA MTUS Drug List": "medroxyprogesterone",
    "__1": "Provera",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: medroxyprogesterone\nBrand Example: Provera\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Progestins\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 238,
    "CA MTUS Drug List": "mefenamic acid",
    "__1": "Ponstel",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: mefenamic acid\nBrand Example: Ponstel\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 239,
    "CA MTUS Drug List": "melatonin",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: melatonin\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Alternative Medicines\nReference in ACOEM Guidelines:\nChronic Pain: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 240,
    "CA MTUS Drug List": "meloxicam",
    "__1": "Mobic",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: meloxicam\nBrand Example: Mobic\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 241,
    "CA MTUS Drug List": "memantine hcl",
    "__1": "Namenda",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: memantine hcl\nBrand Example: Namenda\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Psychotherapeutic and Neurological Agents - Misc.\n(NDMA Receptor Antagonist)\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended, No Recommendation\nLow Back Disorders: Not Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 242,
    "CA MTUS Drug List": "menthol",
    "__1": "Bengay Ultra, Biofreeze",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: menthol\nBrand Example: Bengay Ultra, Biofreeze\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nCervical and Thoracic Spine Disorders: No Recommendation\nChronic Pain: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 243,
    "CA MTUS Drug List": "meperidine hcl",
    "__1": "Demerol",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: meperidine hcl\nBrand Example: Demerol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 244,
    "CA MTUS Drug List": "metaxalone",
    "__1": "Skelaxin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: metaxalone\nBrand Example: Skelaxin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 245,
    "CA MTUS Drug List": "methadone hcl",
    "__1": "Dolophine",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: methadone hcl\nBrand Example: Dolophine\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioid: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 246,
    "CA MTUS Drug List": "methocarbamol",
    "__1": "Robaxin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: methocarbamol\nBrand Example: Robaxin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 247,
    "CA MTUS Drug List": "methyl salicylate",
    "__1": "Bengay Ultra",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: methyl salicylate\nBrand Example: Bengay Ultra\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: No Recommendation\nChronic Pain: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 248,
    "CA MTUS Drug List": "methylphenidate hydrochloride",
    "__1": "Ritalin, Concerta",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: methylphenidate hydrochloride\nBrand Example: Ritalin, Concerta\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: ADHD / Anti-narcolepsy / Anti-Obesity / Anorexiants\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 249,
    "CA MTUS Drug List": "methylprednisolone",
    "__1": "Medrol",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: methylprednisolone\nBrand Example: Medrol\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nCOVID-19 Coronavirus: Recommended\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, No Recommendation\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nWork Related Asthma: Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 250,
    "CA MTUS Drug List": "methylsulfonylmethane",
    "__1": "MSM",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: methylsulfonylmethane\nBrand Example: MSM\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Chemicals (OTC nutraceuticals)\nReference in ACOEM Guidelines:\nHip and Groin Disorders: No Recommendation\nKnee Disorders: No Recommendation\nShoulder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 251,
    "CA MTUS Drug List": "metoclopramide hcl",
    "__1": "Reglan",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: metoclopramide hcl\nBrand Example: Reglan\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 252,
    "CA MTUS Drug List": "metronidazole",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: metronidazole\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 253,
    "CA MTUS Drug List": "metronidazole oral",
    "__1": "Flagyl",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: metronidazole oral\nBrand Example: Flagyl\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anti-Infective Agents - Misc.\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 254,
    "CA MTUS Drug List": "miconazole nitrate",
    "__1": "Micatin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: miconazole nitrate\nBrand Example: Micatin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 255,
    "CA MTUS Drug List": "midazolam hcl",
    "__1": "Versed",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: midazolam hcl\nBrand Example: Versed\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 256,
    "CA MTUS Drug List": "mifepristone",
    "__1": "Mifeprex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: mifepristone\nBrand Example: Mifeprex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Endocrine and Metabolic Agents - (misc)\nReference in ACOEM Guidelines:\nDepressive Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 257,
    "CA MTUS Drug List": "milnacipran",
    "__1": "Savella",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: milnacipran\nBrand Example: Savella\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Psychotherapeutic and Neurological Agents - Misc. (Anti-depressant)\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 258,
    "CA MTUS Drug List": "minocycline hcl",
    "__1": "Minocin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: minocycline hcl\nBrand Example: Minocin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Tetracyclines)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nDepressive Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 259,
    "CA MTUS Drug List": "mirtazapine",
    "__1": "Remeron",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: mirtazapine\nBrand Example: Remeron\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 260,
    "CA MTUS Drug List": "misoprostol",
    "__1": "Cytotec",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: misoprostol\nBrand Example: Cytotec\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ulcer Drugs\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 261,
    "CA MTUS Drug List": "modafinil",
    "__1": "Provigil",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: modafinil\nBrand Example: Provigil\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: ADHD / Anti-narcolepsy / Anti-Obesity / Anorexiants\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 262,
    "CA MTUS Drug List": "mometasone furoate",
    "__1": "Asmanex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: mometasone furoate\nBrand Example: Asmanex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 263,
    "CA MTUS Drug List": "mometasone furoate (topical)",
    "__1": "Elocon",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: mometasone furoate (topical)\nBrand Example: Elocon\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 264,
    "CA MTUS Drug List": "montelukast sodium",
    "__1": "Singluair",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: montelukast sodium\nBrand Example: Singluair\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 265,
    "CA MTUS Drug List": "morphine sulfate",
    "__1": "MSIR",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: morphine sulfate\nBrand Example: MSIR\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nOpioids: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 266,
    "CA MTUS Drug List": "morphine sulfate extended release",
    "__1": "MS Contin, Kadian, Avinza",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: morphine sulfate extended release\nBrand Example: MS Contin, Kadian, Avinza\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 267,
    "CA MTUS Drug List": "moxifloxacin hcl",
    "__1": "Avelox",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: moxifloxacin hcl\nBrand Example: Avelox\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Fluoroquinolones)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 268,
    "CA MTUS Drug List": "moxifloxacin hcl ophthalmic",
    "__1": "Vigamox",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: moxifloxacin hcl ophthalmic\nBrand Example: Vigamox\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Antibiotics)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 269,
    "CA MTUS Drug List": "mupirocin",
    "__1": "Bactroban",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: mupirocin\nBrand Example: Bactroban\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 270,
    "CA MTUS Drug List": "nabilone",
    "__1": "Cesamet",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: nabilone\nBrand Example: Cesamet\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nDepressive Disorders: Not Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 271,
    "CA MTUS Drug List": "nabumetone",
    "__1": "Relafen",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: nabumetone\nBrand Example: Relafen\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 272,
    "CA MTUS Drug List": "n-acetyl-l-cysteine",
    "__1": "NAC",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: n-acetyl-l-cysteine\nBrand Example: NAC\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Nutrients\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 273,
    "CA MTUS Drug List": "naloxone hcl",
    "__1": "Narcan, Zimhi, Kloxxado",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: naloxone hcl\nBrand Example: Narcan, Zimhi, Kloxxado\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidotes and Specific Antagonists\nReference in ACOEM Guidelines:\nOpioid: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 274,
    "CA MTUS Drug List": "naltrexone hydrochloride",
    "__1": "Revia",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: naltrexone hydrochloride\nBrand Example: Revia\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidotes and Specific Antagonists\nReference in ACOEM Guidelines:\nOpioids: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 275,
    "CA MTUS Drug List": "naproxen",
    "__1": "Aleve, Naprosyn",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: naproxen\nBrand Example: Aleve, Naprosyn\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 276,
    "CA MTUS Drug List": "naratriptan hcl",
    "__1": "Amerge",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: naratriptan hcl\nBrand Example: Amerge\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 277,
    "CA MTUS Drug List": "natamycin ophth",
    "__1": "Natacyn",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: natamycin ophth\nBrand Example: Natacyn\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antifungals\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 278,
    "CA MTUS Drug List": "nedocromil",
    "__1": "Alocril",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: nedocromil\nBrand Example: Alocril\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophtalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 279,
    "CA MTUS Drug List": "nefazodone hcl",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: nefazodone hcl\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nPost-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 280,
    "CA MTUS Drug List": "neomycin sulfate",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: neomycin sulfate\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 281,
    "CA MTUS Drug List": "neomycin/polymyxin b/bacitracin",
    "__1": "Neosporin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: neomycin/polymyxin b/bacitracin\nBrand Example: Neosporin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 282,
    "CA MTUS Drug List": "nifedipine",
    "__1": "Procardia",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: nifedipine\nBrand Example: Procardia\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Calcium Channel Blockers\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 283,
    "CA MTUS Drug List": "nitroglycerin transdermal",
    "__1": "Nitro-Dur",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: nitroglycerin transdermal\nBrand Example: Nitro-Dur\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antianginal Agents (Glyceril trinitrate patches)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 284,
    "CA MTUS Drug List": "nizatidine",
    "__1": "Axid",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: nizatidine\nBrand Example: Axid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ulcer Drugs (H2 receptor blocker)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 285,
    "CA MTUS Drug List": "nortriptyline hcl",
    "__1": "Pamelor",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: nortriptyline hcl\nBrand Example: Pamelor\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 286,
    "CA MTUS Drug List": "nystatin/triamcinolone",
    "__1": "Mycolog II",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: nystatin/triamcinolone\nBrand Example: Mycolog II\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 287,
    "CA MTUS Drug List": "ofloxacin",
    "__1": "Floxin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ofloxacin\nBrand Example: Floxin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Fluoroquinolones\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 288,
    "CA MTUS Drug List": "ofloxacin ophthalmic solution",
    "__1": "Ocuflox",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ofloxacin ophthalmic solution\nBrand Example: Ocuflox\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 289,
    "CA MTUS Drug List": "olanzapine",
    "__1": "Zyprexa",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: olanzapine\nBrand Example: Zyprexa\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nTraumatic Brain Injury: Recommended\nPost-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 290,
    "CA MTUS Drug List": "olanzapine/fluoxetine",
    "__1": "Symbyax",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: olanzapine/fluoxetine\nBrand Example: Symbyax\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Psychotherapeutic and Neurologic Agents - Misc.\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 291,
    "CA MTUS Drug List": "olopatadine hcl",
    "__1": "Pataday, Patanol",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: olopatadine hcl\nBrand Example: Pataday, Patanol\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihistamine and/or mast cell stabilization\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 292,
    "CA MTUS Drug List": "omega-3",
    "__1": "Omega-3 Fatty Acids",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: omega-3\nBrand Example: Omega-3 Fatty Acids\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Nutrients\nReference in ACOEM Guidelines:\nDepressive Disorders: No Recommendation\nPost-Traumatic Stress Disorder (Not Recommended) Shoulder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 293,
    "CA MTUS Drug List": "omeprazole",
    "__1": "Prilosec",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: omeprazole\nBrand Example: Prilosec\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 294,
    "CA MTUS Drug List": "ondansetron",
    "__1": "Zofran ODT",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ondansetron\nBrand Example: Zofran ODT\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nChronic Pain: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 295,
    "CA MTUS Drug List": "ondansetron hcl",
    "__1": "Zofran",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ondansetron hcl\nBrand Example: Zofran\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nChronic Pain: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 296,
    "CA MTUS Drug List": "orphenadrine citrate",
    "__1": "Norflex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: orphenadrine citrate\nBrand Example: Norflex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 297,
    "CA MTUS Drug List": "oxaprozin",
    "__1": "Daypro",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: oxaprozin\nBrand Example: Daypro\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 298,
    "CA MTUS Drug List": "oxazepam",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: oxazepam\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Antianxiety Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 299,
    "CA MTUS Drug List": "oxcarbazepine",
    "__1": "Trileptal",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: oxcarbazepine\nBrand Example: Trileptal\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation\nLow Back Disorders: No Recommendation\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 300,
    "CA MTUS Drug List": "oxycodone er",
    "__1": "OxyContin, Xtampza ER",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: oxycodone er\nBrand Example: OxyContin, Xtampza ER\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Not Applicable\nReference in ACOEM Guidelines:\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 301,
    "CA MTUS Drug List": "oxycodone hcl",
    "__1": "Roxicodone",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: oxycodone hcl\nBrand Example: Roxicodone\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nOpioids: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 302,
    "CA MTUS Drug List": "oxycodone/acetaminophen",
    "__1": "Percocet",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: oxycodone/acetaminophen\nBrand Example: Percocet\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 days\nPeri-Op: 4 days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nOpioids: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 303,
    "CA MTUS Drug List": "oxymorphone hydrochloride",
    "__1": "Opana, Opana ER",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: oxymorphone hydrochloride\nBrand Example: Opana, Opana ER\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 304,
    "CA MTUS Drug List": "oxytocin",
    "__1": "Pitocin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: oxytocin\nBrand Example: Pitocin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Oxytocics\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 305,
    "CA MTUS Drug List": "pantoprazole sodium",
    "__1": "Protonix",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: pantoprazole sodium\nBrand Example: Protonix\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 306,
    "CA MTUS Drug List": "paroxetine hcl",
    "__1": "Paxil",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: paroxetine hcl\nBrand Example: Paxil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended, Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 307,
    "CA MTUS Drug List": "penicillin v potassium",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: penicillin v potassium\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antibiotics (Penicillins)\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 308,
    "CA MTUS Drug List": "pentazocine/naloxone hcl",
    "__1": "Talwin NX",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: pentazocine/naloxone hcl\nBrand Example: Talwin NX\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 309,
    "CA MTUS Drug List": "pentoxifylline",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: pentoxifylline\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Hematological Agents - Misc.\nReference in ACOEM Guidelines:\nDepressive Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 310,
    "CA MTUS Drug List": "perphenazine",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: perphenazine\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 311,
    "CA MTUS Drug List": "phenelzine sulfate",
    "__1": "Nardil",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: phenelzine sulfate\nBrand Example: Nardil\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDepressive Disorders: Recommended\nPost-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 312,
    "CA MTUS Drug List": "phenobarbital",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: phenobarbital\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 313,
    "CA MTUS Drug List": "phenytoin",
    "__1": "Dilantin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: phenytoin\nBrand Example: Dilantin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nTraumatic Brain Injury: Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 314,
    "CA MTUS Drug List": "pioglitazone hcl",
    "__1": "Actos",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: pioglitazone hcl\nBrand Example: Actos\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidiabetics\nReference in ACOEM Guidelines:\nDepressive Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 315,
    "CA MTUS Drug List": "piroxicam",
    "__1": "Feldene",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: piroxicam\nBrand Example: Feldene\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 316,
    "CA MTUS Drug List": "pitavastatin calcium",
    "__1": "Livalo",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: pitavastatin calcium\nBrand Example: Livalo\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 317,
    "CA MTUS Drug List": "pitavastatin magnesium",
    "__1": "Zypitamag",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: pitavastatin magnesium\nBrand Example: Zypitamag\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 318,
    "CA MTUS Drug List": "polyvinyl alcohol 1.4% lu",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: polyvinyl alcohol 1.4% lu\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 319,
    "CA MTUS Drug List": "polyvinyl alcohol-povidine (ophth)",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: polyvinyl alcohol-povidine (ophth)\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 320,
    "CA MTUS Drug List": "pramipexole dihydrochloride",
    "__1": "Mirapex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: pramipexole dihydrochloride\nBrand Example: Mirapex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiparkinson and Related Therapy Agents\nReference in ACOEM Guidelines:\nChronic Pain: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 321,
    "CA MTUS Drug List": "pravastatin sodium",
    "__1": "Pravachol",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: pravastatin sodium\nBrand Example: Pravachol\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Non-Exempt\nPeri-Op: Not Applicable\nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 322,
    "CA MTUS Drug List": "prazosin hcl",
    "__1": "Minpress",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: prazosin hcl\nBrand Example: Minpress\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihypertensives\nReference in ACOEM Guidelines:\nPost-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 323,
    "CA MTUS Drug List": "prednicarbate",
    "__1": "Dermatop",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: prednicarbate\nBrand Example: Dermatop\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 324,
    "CA MTUS Drug List": "prednisolone",
    "__1": "Orapred",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: prednisolone\nBrand Example: Orapred\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, No Recommendation\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 325,
    "CA MTUS Drug List": "prednisolone acetate",
    "__1": "Pred Forte, Pred Mild",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: prednisolone acetate\nBrand Example: Pred Forte, Pred Mild\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Steroid)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 326,
    "CA MTUS Drug List": "prednisolone sodium ophth",
    "__1": "Omnipred",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: prednisolone sodium ophth\nBrand Example: Omnipred\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Steroid)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 327,
    "CA MTUS Drug List": "prednisone",
    "__1": "Sterapred",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: prednisone\nBrand Example: Sterapred\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Corticosteroids\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, No Recommendation\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: Recommended, Not Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 328,
    "CA MTUS Drug List": "pregabalin",
    "__1": "Lyrica",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: pregabalin\nBrand Example: Lyrica\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: No Recommendation\nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 329,
    "CA MTUS Drug List": "pregabalin (once-daily)",
    "__1": "Lyrica CR",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: pregabalin (once-daily)\nBrand Example: Lyrica CR\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Psychotherapeutic and Neurological Agents - Misc\nReference in ACOEM Guidelines:\nAnxiety Disorders: Not Recommended\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 330,
    "CA MTUS Drug List": "probenecid",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: probenecid\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Gout Agents\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 331,
    "CA MTUS Drug List": "prochlorperazine maleate",
    "__1": "Compazine",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: prochlorperazine maleate\nBrand Example: Compazine\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 332,
    "CA MTUS Drug List": "progesterone",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: progesterone\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Progestins\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 333,
    "CA MTUS Drug List": "promethazine hcl",
    "__1": "Phenergan",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: promethazine hcl\nBrand Example: Phenergan\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 334,
    "CA MTUS Drug List": "proparacaine hcl",
    "__1": "Alcaine",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: proparacaine hcl\nBrand Example: Alcaine\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Anesthetic)\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 335,
    "CA MTUS Drug List": "propranolol hcl",
    "__1": "Inderal",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: propranolol hcl\nBrand Example: Inderal\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Beta Blockers\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nTraumatic Brain Injury: Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 336,
    "CA MTUS Drug List": "protriptyline hcl",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: protriptyline hcl\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nChronic Pain: Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 337,
    "CA MTUS Drug List": "pyridostigmine bromide",
    "__1": "Mestinon",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: pyridostigmine bromide\nBrand Example: Mestinon\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antimyasthenic / Cholinergic Agents\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 338,
    "CA MTUS Drug List": "quetiapine fumarate",
    "__1": "Seroquel",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: quetiapine fumarate\nBrand Example: Seroquel\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nChronic Pain: No Recommendation\nDepressive Disorders: Recommended\nTraumatic Brain Injury: Recommended\nPost-Traumatic Stress Disorder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 339,
    "CA MTUS Drug List": "rabeprazole sodium",
    "__1": "Aciphex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: rabeprazole sodium\nBrand Example: Aciphex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ulcer Drugs (Proton pump inhibitor)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHand, Wrist, and Forearm Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 340,
    "CA MTUS Drug List": "raloxifene hydrochloride",
    "__1": "Evista",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: raloxifene hydrochloride\nBrand Example: Evista\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Endocrine and Metabolic Agents- Misc.\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 341,
    "CA MTUS Drug List": "regular insulin",
    "__1": "Humulin R",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: regular insulin\nBrand Example: Humulin R\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidiabetics\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 342,
    "CA MTUS Drug List": "ribavirin",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ribavirin\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antivirals\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 343,
    "CA MTUS Drug List": "riboflavin",
    "__1": "Vitamin B-2",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: riboflavin\nBrand Example: Vitamin B-2\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nDepressive Disorders: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 344,
    "CA MTUS Drug List": "risedronate sodium",
    "__1": "Actonel",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: risedronate sodium\nBrand Example: Actonel\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Endocrine and Metabolic Agents- Misc. (Bisphosphonate)\nReference in ACOEM Guidelines:\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 345,
    "CA MTUS Drug List": "risperidone",
    "__1": "Risperdal",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: risperidone\nBrand Example: Risperdal\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 346,
    "CA MTUS Drug List": "rivaroxaban",
    "__1": "Xarelto",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: rivaroxaban\nBrand Example: Xarelto\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 347,
    "CA MTUS Drug List": "rivastigmine tartrate",
    "__1": "Exelon",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: rivastigmine tartrate\nBrand Example: Exelon\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Psychotherapeutic and Neurological Agents - Misc.\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 348,
    "CA MTUS Drug List": "rizatriptan benzoate",
    "__1": "Maxalt",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: rizatriptan benzoate\nBrand Example: Maxalt\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 349,
    "CA MTUS Drug List": "rolapitant",
    "__1": "Varubi",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: rolapitant\nBrand Example: Varubi\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 350,
    "CA MTUS Drug List": "rosuvastatin calcium",
    "__1": "Crestor",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: rosuvastatin calcium\nBrand Example: Crestor\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nShoulder: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 351,
    "CA MTUS Drug List": "s-adenosylmethionine",
    "__1": "SAM E",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: s-adenosylmethionine\nBrand Example: SAM E\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Alternative Medicines\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 352,
    "CA MTUS Drug List": "salmeterol",
    "__1": "Serevent",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: salmeterol\nBrand Example: Serevent\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 353,
    "CA MTUS Drug List": "salsalate",
    "__1": "Disalcid",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: salsalate\nBrand Example: Disalcid\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - NonNarcotic (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 354,
    "CA MTUS Drug List": "scopolamine",
    "__1": "Transderm Scop",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: scopolamine\nBrand Example: Transderm Scop\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiemetics\nReference in ACOEM Guidelines:\nAntiemetics: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 355,
    "CA MTUS Drug List": "selegiline",
    "__1": "Emsam",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: selegiline\nBrand Example: Emsam\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 356,
    "CA MTUS Drug List": "sertraline hcl",
    "__1": "Zoloft",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: sertraline hcl\nBrand Example: Zoloft\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants (SSRI)\nReference in ACOEM Guidelines:\nAnxiety Disorder: Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Recommended, Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Not Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 357,
    "CA MTUS Drug List": "silver sulfadiazine",
    "__1": "Silvadene",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: silver sulfadiazine\nBrand Example: Silvadene\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 358,
    "CA MTUS Drug List": "simvastatin",
    "__1": "Zocor",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: simvastatin\nBrand Example: Zocor\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antihyperlipidemics\nReference in ACOEM Guidelines:\nDepressive Disorders (No Recommendation) Shoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 359,
    "CA MTUS Drug List": "sodium chloride ophthalmic",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: sodium chloride ophthalmic\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 360,
    "CA MTUS Drug List": "sodium oxybate",
    "__1": "Xyrem",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: sodium oxybate\nBrand Example: Xyrem\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Psychotherapeutic and Neurological Agents - Misc.\nReference in ACOEM Guidelines:\nChronic Pain: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 361,
    "CA MTUS Drug List": "sucralfate",
    "__1": "Carafate",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: sucralfate\nBrand Example: Carafate\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ulcer Drugs\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended\nElbow Disorders: Recommended\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 362,
    "CA MTUS Drug List": "sulfamethoxazole/trimethoprim",
    "__1": "Bactrim",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: sulfamethoxazole/trimethoprim\nBrand Example: Bactrim\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anti-Infective Agents - Misc.\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 363,
    "CA MTUS Drug List": "sulindac",
    "__1": "Clinoril",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: sulindac\nBrand Example: Clinoril\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 364,
    "CA MTUS Drug List": "sumatriptan succinate",
    "__1": "Imitrex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: sumatriptan succinate\nBrand Example: Imitrex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 365,
    "CA MTUS Drug List": "tacrolimus",
    "__1": "Protopic",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tacrolimus\nBrand Example: Protopic\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 366,
    "CA MTUS Drug List": "tapentadol",
    "__1": "Nucynta, Nucynta ER",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tapentadol\nBrand Example: Nucynta, Nucynta ER\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nOpioids: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 367,
    "CA MTUS Drug List": "temazepam",
    "__1": "Restoril",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: temazepam\nBrand Example: Restoril\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines:\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 368,
    "CA MTUS Drug List": "terbinafine hcl",
    "__1": "Lamisil",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: terbinafine hcl\nBrand Example: Lamisil\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antifungals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 369,
    "CA MTUS Drug List": "terbinafine hcl (topical)",
    "__1": "Lamisil",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: terbinafine hcl (topical)\nBrand Example: Lamisil\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 370,
    "CA MTUS Drug List": "tetracaine hcl",
    "__1": "Tetcaine",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tetracaine hcl\nBrand Example: Tetcaine\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Anesthetic)\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 371,
    "CA MTUS Drug List": "tetracycline hcl",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tetracycline hcl\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Tetracyclines\nReference in ACOEM Guidelines:\nEye: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 372,
    "CA MTUS Drug List": "thalidomide",
    "__1": "Thalomid",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: thalidomide\nBrand Example: Thalomid\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Assorted Classes\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 373,
    "CA MTUS Drug List": "theophylline",
    "__1": "Theo-24, Theo-Dur",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: theophylline\nBrand Example: Theo-24, Theo-Dur\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 374,
    "CA MTUS Drug List": "tiagabine hcl",
    "__1": "Gabitril",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tiagabine hcl\nBrand Example: Gabitril\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nPost-Traumatic Stress Disorder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 375,
    "CA MTUS Drug List": "tizanidine hcl",
    "__1": "Zanaflex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tizanidine hcl\nBrand Example: Zanaflex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 days\nPeri-Op: Not Applicable\nDrug Class: Musculoskeletal Therapy Agents (Muscle Relaxants)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, Not Recommended\nShoulder: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 376,
    "CA MTUS Drug List": "tobramycin ophthalmic",
    "__1": "Tobrex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tobramycin ophthalmic\nBrand Example: Tobrex\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Anti-bacterial)\nReference in ACOEM Guidelines:\nEye: Recommended, Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 377,
    "CA MTUS Drug List": "tolmetin sodium",
    "__1": "Tolectin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tolmetin sodium\nBrand Example: Tolectin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Analgesics - Anti-Inflammatory (NSAID)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended\nChronic Pain: Recommended\nElbow Disorders: Recommended, Not Recommended, No Recommendation\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended, No Recommendation\nHip and Groin Disorders: Recommended, No Recommendation\nKnee Disorders: Recommended, No Recommendation\nLow Back Disorders: Recommended\nShoulder: Recommended\nTraumatic Brain Injury: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 378,
    "CA MTUS Drug List": "tolnaftate",
    "__1": "Tinactin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tolnaftate\nBrand Example: Tinactin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 379,
    "CA MTUS Drug List": "topiramate",
    "__1": "Topamax",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: topiramate\nBrand Example: Topamax\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 380,
    "CA MTUS Drug List": "tramadol hcl",
    "__1": "Ultram",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tramadol hcl\nBrand Example: Ultram\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nOpioids: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 381,
    "CA MTUS Drug List": "tramadol hcl/acetaminophen",
    "__1": "Ultracet",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tramadol hcl/acetaminophen\nBrand Example: Ultracet\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: 4 Days\nDrug Class: Analgesics - Opioid\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended, Not Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended, Not Recommended\nElbow Disorders: Recommended, Not Recommended\nHand, Wrist, and Forearm Disorders: Recommended, Not Recommended\nHip and Groin Disorders: Recommended, Not Recommended\nKnee Disorders: Recommended\nLow Back Disorders: Recommended, Not Recommended\nOpioids: Recommended, Not Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 382,
    "CA MTUS Drug List": "tranexamic acid",
    "__1": "Lysteda",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tranexamic acid\nBrand Example: Lysteda\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Hemostatics\nReference in ACOEM Guidelines:\nEye: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 383,
    "CA MTUS Drug List": "tranylcypromine",
    "__1": "Parnate",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tranylcypromine\nBrand Example: Parnate\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 384,
    "CA MTUS Drug List": "trazodone hcl",
    "__1": "Desyrel, Oleptro",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: trazodone hcl\nBrand Example: Desyrel, Oleptro\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Recommended, Not Recommended, No Recommendation\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: No Recommendation\nShoulder: Recommended, Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 385,
    "CA MTUS Drug List": "triamcinolone acetonide i",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: triamcinolone acetonide i\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 386,
    "CA MTUS Drug List": "trimipramine maleate",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: trimipramine maleate\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 387,
    "CA MTUS Drug List": "trolamine salicylate",
    "__1": "Arthricream",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: trolamine salicylate\nBrand Example: Arthricream\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Dermatologicals\nReference in ACOEM Guidelines:\nHand, Wrist, and Forearm Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 388,
    "CA MTUS Drug List": "tropicamide ophthalmic",
    "__1": "Mydriacyl",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: tropicamide ophthalmic\nBrand Example: Mydriacyl\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Ophthalmic Agents (Anticholinergics)\nReference in ACOEM Guidelines:\nEye: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 389,
    "CA MTUS Drug List": "trypsin",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: trypsin\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Chemicals (Proteolytic enzyme)\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 390,
    "CA MTUS Drug List": "valacyclovir hcl",
    "__1": "Valtrex",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: valacyclovir hcl\nBrand Example: Valtrex\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antivirals\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 391,
    "CA MTUS Drug List": "valproic acid",
    "__1": "Depakene",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: valproic acid\nBrand Example: Depakene\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nAnxiety Disorders: No Recommendation\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nPost-Traumatic Stress Disorder: Not Recommended\nTraumatic Brain Injury: Not Recommended, No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 392,
    "CA MTUS Drug List": "venlafaxine hcl",
    "__1": "Effexor",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: venlafaxine hcl\nBrand Example: Effexor\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nAnxiety Disorders: Recommended\nCervical and Thoracic Spine Disorders: Recommended, Not Recommended\nChronic Pain: Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: No Recommendation\nKnee Disorders: Recommended, Not Recommended, No Recommendation\nLow Back Disorders: Recommended, No Recommendation\nPost-Traumatic Stress Disorder: Recommended\nShoulder: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 393,
    "CA MTUS Drug List": "vilazodone",
    "__1": "Viibryd",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: vilazodone\nBrand Example: Viibryd\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nChronic Pain: Not Recommended\nDepressive Disorders: Recommended\nHip and Groin Disorders: Not Recommended\nKnee Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nPost-Traumatic Stress Disorder: Not Recommended\nShoulder: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 394,
    "CA MTUS Drug List": "vitamin a",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: vitamin a\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 395,
    "CA MTUS Drug List": "vitamin b-1",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: vitamin b-1\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nDepressive Disorders: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 396,
    "CA MTUS Drug List": "vitamin b-12",
    "__1": "Cyanocobalamin, Methylcobalamin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: vitamin b-12\nBrand Example: Cyanocobalamin, Methylcobalamin\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Hematopoietic Agents (Vitamins)\nReference in ACOEM Guidelines:\nCervical and Thoracic Spine Disorders: Not Recommended\nDepressive Disorders: Not Recommended\nElbow Disorders: No Recommendation\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 397,
    "CA MTUS Drug List": "vitamin b-6",
    "__1": "Pyridoxine",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: vitamin b-6\nBrand Example: Pyridoxine\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nElbow Disorders: Not Recommended\nHand, Wrist, and Forearm Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 398,
    "CA MTUS Drug List": "vitamin d",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: vitamin d\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Recommended\nDepressive Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 399,
    "CA MTUS Drug List": "vitamin d3",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: vitamin d3\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Recommended\nChronic Pain: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 400,
    "CA MTUS Drug List": "vitamin e",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: vitamin e\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Vitamins\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: Not Recommended, No Recommendation\nCervical and Thoracic Spine Disorders: Not Recommended\nLow Back Disorders: Not Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 401,
    "CA MTUS Drug List": "vortioxetine",
    "__1": "Trintellix",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: vortioxetine\nBrand Example: Trintellix\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antidepressants\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 402,
    "CA MTUS Drug List": "warfarin sodium",
    "__1": "Coumadin",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: warfarin sodium\nBrand Example: Coumadin\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticoagulants\nReference in ACOEM Guidelines:\nAnkle and Foot Disorders: No Recommendation\nHip and Groin Disorders: Recommended\nKnee Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 403,
    "CA MTUS Drug List": "zafirlukast",
    "__1": "Accolate",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: zafirlukast\nBrand Example: Accolate\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 404,
    "CA MTUS Drug List": "zileuton",
    "__1": "Zyflo",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: zileuton\nBrand Example: Zyflo\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antiasthmatic and Bronchodilator Agents\nReference in ACOEM Guidelines:\nWork Related Asthma: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 405,
    "CA MTUS Drug List": "zinc",
    "__1": "Not Applicable",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: zinc\nBrand Example: Not Applicable\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Minerals & Electrolytes\nReference in ACOEM Guidelines:\nCOVID-19 Coronavirus: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 406,
    "CA MTUS Drug List": "ziprasidone hcl",
    "__1": "Geodon",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: ziprasidone hcl\nBrand Example: Geodon\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Antipsychotics / Antimanic Agents\nReference in ACOEM Guidelines:\nDepressive Disorders: Recommended\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 407,
    "CA MTUS Drug List": "zolmitriptan",
    "__1": "Zomig",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: zolmitriptan\nBrand Example: Zomig\nExempt\\Non-Exempt: Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Migraine Products\nReference in ACOEM Guidelines:\nTraumatic Brain Injury: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 408,
    "CA MTUS Drug List": "zolpidem tartrate",
    "__1": "Ambien",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: zolpidem tartrate\nBrand Example: Ambien\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: 4 Days\nPeri-Op: Not Applicable\nDrug Class: Hypnotics / Sedatives / Sleep Disorder Agents\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nDepressive Disorders: Recommended\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  },
  {
    "": 409,
    "CA MTUS Drug List": "zonisamide",
    "__1": "Zonegran",
    "__2": "California Medical Treatment Utilization Schedule (MTUS)/ACOEM Practice Guidelines\nMTUS Drug List v.12 (Effective November 1, 2024) \nDrug Formulary\nDrug Ingredient: zonisamide\nBrand Example: Zonegran\nExempt\\Non-Exempt: Non-Exempt\nSpecial Fill: Not Applicable\nPeri-Op: Not Applicable\nDrug Class: Anticonvulsants\nReference in ACOEM Guidelines:\nChronic Pain: Not Recommended\nHip and Groin Disorders: Not Recommended\nLow Back Disorders: No Recommendation\nDosage Form: Not Applicable\nStrength: Not Applicable\nUnique Pharmaceutical Identifier(s): Not Applicable\nACOEM Guidelines Copyright Reed Group Ltd."
  }
]
